Farms.com Home   News

Ethanol Stocks Swell, Production Down

By John Perkins

Ongoing demand uncertainties and declining margins are contributing to a decline in ethanol demand.

Ongoing demand uncertainties and declining margins are contributing to a decline in ethanol demand.

The U.S. Energy Information Administration says production averaged 1.061 million barrels a day, down 16,000 on the week and 26,000 on the year.

Iowa State University’s Center for Agricultural and Rural Development reports margins for the average producer in Iowa fell to the lowest levels this year.

Another sign of slowing demand, stocks jumped 1.152 million barrels to 24.409 million, the largest supply since mid-April and 3.526 million above a year ago.

The Renewable Fuels Association says net inputs by ethanol refiners and blenders were up 3.7% from the previous week, but the volume of gasoline supplied to the market fell 1.2%.

Iowa State University’s Center for Agricultural and Rural Development reports margins for the average producer in Iowa fell to the lowest levels this year.

Another sign of slowing demand, stocks jumped 1.152 million barrels to 24.409 million, the largest supply since mid-April and 3.526 million above a year ago.

The Renewable Fuels Association says net inputs by ethanol refiners and blenders were up 3.7% from the previous week, but the volume of gasoline supplied to the market fell 1.2%.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.